A Multi-Epitope Peptide Vaccine Candidateagainst Triple Negative Breast Cancer (TNBC): A Novel Approachin Silico Design
- سال انتشار: 1402
- محل انتشار: اولین کنگره بین المللی ژنومیک سرطان
- کد COI اختصاصی: CGC01_076
- زبان مقاله: انگلیسی
- تعداد مشاهده: 184
نویسندگان
Biophysics Department, Faculty of Biological Sciences, TarbiatModares University, Tehran, IRAN
Department of Biology, Science and Research Branch Tehran,Islamic Azad University, Tehran, Iran
Department of Tissue Engineering and Applied Cell Sciences,School of Advanced Technologies in Medicine, Shahid BeheshtiUniversity of Medical Sciences, Tehran, Iran
Department of R&D, RahavardCell Co, Tehran, IRAN
چکیده
Introduction: This article presents a bioinformatics approachto designing a vaccine against Triple Negative Breast Cancer(TNBC), a hard-to-treat and aggressive form of breast cancer.The study identifies the targets for the vaccine and outlines theprocess for designing the vaccine using computational tools.Materials and Methods: The study identifies nine proteins astargets for the vaccine, selected based on their ability to bind tothe MHC system. Linear Epitope and Conformational Epitopealgorithms were used to identify epitopes within these proteins.A vaccine candidate was designed using a suitable linker andadjuvant, and computational tests were carried out to ensurethat the vaccine met the necessary physicochemical propertiesand structural analysis.Results: The resulting vaccine candidate passed all computationaltests and showed high population coverage in variouscountries, including Iran, France, England, Spain, China, Japan,India, Saudi Arabia, Israel, the United States, Brazil, Guinea-Bissau, and Australia. The proposed vaccine targets surfaceantigens of TNBC cells, providing a new way to stimulate theimmune system to attack the cancer cells.Conclusion: This study demonstrates the potential of bioinformaticsapproaches in designing effective cancer vaccines.The vaccine candidate designed using the identified targets forTNBC offers a promising approach to treating this hard-to-treatform of breast cancer. The study opens new avenues for furtherresearch and development of vaccines against other types ofcancer.کلیدواژه ها
Triple Negative Breast Cancer, TNBC, Multi epitopevaccine, Bioinformatics, Immunoinformatics, Epitopeمقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.